“Tyrosine Kinase Inhibitors: New Molecules in Non-Small Cell Lung Cancer (EGFR AND ALK)”. ADMET and DMPK, vol. 5, no. 1, Mar. 2017, pp. 1-8, https://doi.org/10.5599/admet.5.1.352.